Service interruption on Monday 11 July from 12:30 to 13:00: all the sites of the CCSD (HAL, Epiciences, SciencesConf, AureHAL) will be inaccessible (network hardware connection).
Skip to Main content Skip to Navigation
Preprints, Working Papers, ...

Chromatin accessibility combined with enhancer clusters activation mediates heterogeneous response to dexamethasone in myeloma cells

Abstract : Glucocorticoids (GC) effects occur through binding to the GC receptor (GR) which, once translocated to the nucleus, binds to GC response elements (GREs) to activate or repress target genes. Among GCs, dexamethasone (Dex) is widely used in treatment of multiple myeloma (MM), mainly in combination regimens. However, despite a definite benefit, all patients relapse. Moreover, while GC efficacy can be largely attributed to lymphocyte-specific apoptosis, its molecular basis remains elusive. To determine the functional role of GR binding in myeloma cells, we generated bulk and single cell multi-omic data and high-resolution contact maps of active enhancers and target genes. We show that a minority (6%) of GR binding sites are associated with enhancer activity gains and increased interaction loops. We find that enhancers contribute to regulate gene activity through combinatorial assembly of large stretches of enhancers and/or enhancer cliques. Furthermore, one enhancer, proximal to GR-responsive genes, is predominantly associated with increased chromatin accessibility and higher H3K27ac occupancy. Finally, we show that Dex exposure leads to co-accessibility changes between predominant enhancer and other regulatory regions of the interaction network. Notably, these epigenomic changes are associated with cell-to-cell transcriptional heterogeneity. As consequences, BIM critical for GR-induced apoptosis and CXCR4 protective from chemotherapy-induced apoptosis are rather upregulated in different cells. In summary, our work provides new insights into the molecular mechanisms involved in Dex escape.
Document type :
Preprints, Working Papers, ...
Complete list of metadata

https://www.hal.inserm.fr/inserm-03364330
Contributor : Elizabeth Bernardo Connect in order to contact the contributor
Submitted on : Monday, October 4, 2021 - 3:39:15 PM
Last modification on : Wednesday, April 27, 2022 - 4:40:12 AM
Long-term archiving on: : Wednesday, January 5, 2022 - 6:49:26 PM

File

Minvielle2021Eq11.pdf
Publisher files allowed on an open archive

Identifiers

Citation

Victor Gaborit, Jonathan Cruard, Catherine Guérin-Charbonnel, Jennifer Derrien, Jean-Baptiste Alberge, et al.. Chromatin accessibility combined with enhancer clusters activation mediates heterogeneous response to dexamethasone in myeloma cells. 2021. ⟨inserm-03364330⟩

Share

Metrics

Record views

99

Files downloads

73